Royal Society of Chemistry, Organic and Biomolecular Chemistry, 10(17), p. 2734-2746, 2019
DOI: 10.1039/c9ob00122k
Full text: Unavailable
Allosteric regulators of clinically important enzymes are gaining popularity as alternatives to competitive inhibitors.